S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
2 stocks that faded their price gaps after crushing earnings
Give up the OPEC fight with these 3 stocks, Buffett-certified
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
10-year yield is below 4.5%...these dividend growth yields aren’t
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is there money hiding under these 2 mattress stocks?
3 reasons a squeeze could be in Paramount's coming attractions

Genius Sports (GENI) Stock Forecast & Price Target

$5.48
-0.04 (-0.73%)
(As of 11/27/2023 ET)
Compare
Today's Range
$5.42
$5.55
50-Day Range
$4.69
$5.52
52-Week Range
$3.12
$8.45
Volume
1.56 million shs
Average Volume
1.52 million shs
Market Capitalization
$1.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.32

Genius Sports Consensus Analyst Rating and Stock Price Forecast (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Buy
Based on 9 Analyst Ratings

Analysts' Consensus Price Target

$9.32
70.20% Upside
High Forecast$12.00
Average Forecast$9.32
Low Forecast$8.00
TypeCurrent Forecast
11/28/22 to 11/28/23
1 Month Ago
10/29/22 to 10/29/23
3 Months Ago
8/30/22 to 8/30/23
1 Year Ago
11/28/21 to 11/28/22
Consensus Rating
Buy
Buy
Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
9 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
4 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$9.32$9.15$9.28$8.83
Predicted Upside70.20% Upside49.33% Upside46.21% Upside115.54% Upside
Get Genius Sports Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GENI and its competitors with MarketBeat's FREE daily newsletter.


GENI Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GENI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Genius Sports Stock vs. The Competition

TypeGenius SportsComputer and Technology CompaniesS&P 500
Consensus Rating Score
3.00
2.55
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside70.20% Upside1,011.56% Upside5,661.32% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/14/2023Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$15.00 ➝ $12.00+140.00%
11/14/2023Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$10.00+94.74%
11/14/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$10.00 ➝ $9.00+75.27%
10/12/2023Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$8.00+54.29%
9/27/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Outperform ➝ Market Outperform$9.00+67.60%
8/8/2023Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$7.00 ➝ $8.50+23.91%
8/8/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$7.00 ➝ $10.00+45.77%
8/8/2023B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$9.00 ➝ $10.00+44.93%
7/19/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$7.00 ➝ $9.00+19.36%
7/11/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$6.00 ➝ $9.00+20.48%
3/13/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$10.00 ➝ $8.00+88.24%
(Data available from 11/28/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












GENI Price Target - Frequently Asked Questions

What is Genius Sports's consensus rating and price target?

According to the issued ratings of 9 analysts in the last year, the consensus rating for Genius Sports stock is Buy based on the current 9 buy ratings for GENI. The average twelve-month price prediction for Genius Sports is $9.32 with a high price target of $12.00 and a low price target of $8.00. Learn more on GENI's analyst rating history.

Do Wall Street analysts like Genius Sports more than its competitors?

Analysts like Genius Sports more than other Computer and Technology companies. The consensus rating for Genius Sports is Buy while the average consensus rating for computer and technology companies is Moderate Buy. Learn more on how GENI compares to other companies.

Does Genius Sports's stock price have much upside?

According to analysts, Genius Sports's stock has a predicted upside of 65.76% based on their 12-month stock forecasts.

What analysts cover Genius Sports?

Genius Sports has been rated by Benchmark, Cantor Fitzgerald, Craig Hallum, JMP Securities, and Needham & Company LLC in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:GENI) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -